International Clinical Trials in Neurology

Australia

• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Adelaide, South Australia; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Brisbane, Queensland; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Concord, New South Wales; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Fitzroy; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Brisbane, Queensland; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Chatswood, New South Wales; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Clayton, Victoria; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Fitzroy, Victoria; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Maroochydore, Queensland; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Parkville, Victoria; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  West Heidelberg; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Woodville, South Australia; UCB Clinical Trial Call Center
  
  

Austria

• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Graz; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Innsbrick; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Linz; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Wien; UCB Clinical Trial Call Center
  
  
• Narcolepsy: Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
  Graz; UCB Clinical Trial Call Center
  
  
• Narcolepsy: Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
  Inssbruck; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Innsbruck; UCB Clinical Trial Call Center
  
  

Belgium

• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Brugge; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Godinne; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Leuven; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Montignies Sur Sambre; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Antwerpen; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Gent; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Liege; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Saint-Vith; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  EDEGEM; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  LEUVEN; UCB Clinical Trial Call Center
  
  
• Epilepsy: Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
  Brussels; UCB Clinical Trial Call Center
  
  
• Epilepsy: Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
  Gent; UCB Clinical Trial Call Center
  
  
• Epilepsy: Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
  Leuven; UCB Clinical Trial Call Center
  
  
• Epilepsy: Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
  Liege; UCB Clinical Trial Call Center
  
  
• Narcolepsy: Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
  Liege; UCB Clinical Trial Call Center
  
  

Brazil

• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Campinas; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Curitiba; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Florianópolis; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Porto Alegre; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Ribeirao Pret; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Salvador; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Sao Jose do Rio Preto; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Sao Paulo; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Sao Paulo; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Sao Paulo; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Sao Paulo; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Sao Paulo; UCB Clinical Trial Call Center
  
  

Canada

• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  London, Ontario; London Health Sciences Center University Campus
  
  
• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Montreal, Quebec; Notre Dame
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Montreal, Quebec; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Quebec, QC; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Vancouver, BC; UCB Clinical Trial Call Center
  
  
• Migraine and Cluster Headaches: Percitaneous Closure of Patent Foramen Ovale in Migraine with Aura - A Randomized Prospective Study: PRIMA Migraine Clinical Trial
  Calgary, Alberta; University of Calgary - Foothills Hospital
  
  
• Migraine and Cluster Headaches: Percitaneous Closure of Patent Foramen Ovale in Migraine with Aura - A Randomized Prospective Study: PRIMA Migraine Clinical Trial
  Hamilton, Ontario; St. Joseph Healthcare
  
  
• Migraine and Cluster Headaches: Percitaneous Closure of Patent Foramen Ovale in Migraine with Aura - A Randomized Prospective Study: PRIMA Migraine Clinical Trial
  Montreal, Quebec; Montreal Heart Institute
  
  
• Migraine and Cluster Headaches: Percitaneous Closure of Patent Foramen Ovale in Migraine with Aura - A Randomized Prospective Study: PRIMA Migraine Clinical Trial
  Quebec City, Quebec; Centre Hospitalier Universitaire de Quebec
  
  
• Migraine and Cluster Headaches: Percitaneous Closure of Patent Foramen Ovale in Migraine with Aura - A Randomized Prospective Study: PRIMA Migraine Clinical Trial
  Toronto, Ontario; Davisville Medical Center
  
  
• Migraine and Cluster Headaches: Whether subjects with percutaneous PFO closure experience a reduction in migraine attacks.
  Various Cities; Research Site
  
  
• Neurologic Disorders: Whether subjects with percutaneous PFO closure experience a reduction in migraine attacks.
  Various Cities; Research Site
  
  
• Parkinson's Disease: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  London, Ontario; London Health Sciences Center University Campus
  
  
• Parkinson's Disease: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Montreal, Quebec; Notre Dame
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Edmonton, Alberta; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Greenfield Park, Quebec; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Montreal, Quebec; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Montreal, Quebec; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Quebec City, Quebec; UCB Clinical Trial Call Center
  
  

Chile

• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  San Miguel, Santiago; Complejo Asistencial Barros Luco
  
  
• Parkinson's Disease: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  San Miguel, Santiago; Complejo Asistencial Barros Luco
  
  

Colombia

• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Bogota; Asociacion Medica De Los Andes
  
  
• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Bucaramanga; Fundacion Cardiovascular del Oriente Colombiano
  
  
• Parkinson's Disease: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Bogota; Asociacion Medica De Los Andes
  
  
• Parkinson's Disease: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Bucaramanga; Fundacion Cardiovascular del Oriente Colombiano
  
  

Czech Republic

• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Beroun; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Ostrava Trebovice; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Praha 5; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Zlin; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  BEROUN; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  BRNO; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  BRNO; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  CESKE BUDEJOVICE; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  PRAHA 1; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  PRAHA 5; UCB Clinical Trial Call Center
  
  

Denmark

• Alzheimer Disease: A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.
  København; Research Site:
  
  
• Alzheimer Disease: A Single Dose Study of R1450 in Patients With Alzheimer Disease.
  København; Research Site:
  
  

Finland

• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Kuopio; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Oulu; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Seinajoki; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Tampere; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Helsinki; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Kuopio; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Oulu; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Oys; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Seinajoki; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Tampere; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Tampere; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Hyvinkää; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Oulu; UCB Clinical Trial Call Center
  
  

France

• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Lille cedex; C.H.R.U de Lille, Hopital R. Salengro Service de Neuroligie A
  
  
• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Marseille Cedex 05; A.P. Marseille, Hopital de la Timone
  
  
• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Nantes Cedex 1; C.H.R.U de nantes Hopital Guillaume et Rene Laenn
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Angers Cedex 9; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Bethune; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Bron; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Dijon; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Lille; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Montpellier Cedex; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Nancy; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Paris; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Paris; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Reims; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Rennes; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Roanne; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Strasbourg; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Angers Cedex 1; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Bethune; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Dijon; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Lyon; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Marseille; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Montpellier Cedex 5; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Rennes; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  St Pierre Cedex; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Strasbourg; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Toulouse Cedex 04; UCB Clinical Trial Call Center
  
  
• Epilepsy: Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
  Amiens; UCB Clinical Trial Call Center
  
  
• Epilepsy: Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
  Lille; UCB Clinical Trial Call Center
  
  
• Epilepsy: Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
  Paris; UCB Clinical Trial Call Center
  
  
• Epilepsy: Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
  Reims; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Lille cedex; C.H.R.U de Lille, Hopital R. Salengro Service de Neuroligie A
  
  
• Parkinson's Disease: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Marseille Cedex 05; A.P. Marseille, Hopital de la Timone
  
  
• Parkinson's Disease: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Nantes Cedex 1; C.H.R.U de nantes Hopital Guillaume et Rene Laenn
  
  

Germany

• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Berlin; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Bernau; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Bielefeld; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Erlangen; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Göttingen; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Jena; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  München; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Berlin; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Freiburg; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Kehl, Kork; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Liegau-Augustusbad; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Munchen; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Ulm; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Berlin; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Bonn; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Frankfurt; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Freiburg; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Kehl; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Munchen; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Munchen; UCB Clinical Trial Call Center
  
  
• Epilepsy: Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
  Heidelberg; UCB Clinical Trial Call Center
  
  
• Epilepsy: Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
  Kehl; UCB Clinical Trial Call Center
  
  
• Epilepsy: Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
  Kiel; UCB Clinical Trial Call Center
  
  
• Epilepsy: Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
  Münster; UCB Clinical Trial Call Center
  
  
• Migraine and Cluster Headaches: Percitaneous Closure of Patent Foramen Ovale in Migraine with Aura - A Randomized Prospective Study: PRIMA Migraine Clinical Trial
  Münster; Universitätsklinicum Munster
  
  
• Migraine and Cluster Headaches: Whether subjects with percutaneous PFO closure experience a reduction in migraine attacks.
  Various Cities; Research Site
  
  
• Narcolepsy: Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
  Schwalmstadt; UCB Clinical Trial Call Center
  
  
• Neurologic Disorders: Whether subjects with percutaneous PFO closure experience a reduction in migraine attacks.
  Various Cities; Research Site
  
  
• Parkinson's Disease: A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery.
  Augsburg; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery.
  Bochum; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery.
  Bonn; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery.
  Bremerhaven; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery.
  Dortmund; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery.
  Dresden; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery.
  Hanau; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery.
  Ingolstadt; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery.
  Kiel; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery.
  Schwerin; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery.
  Stralsund; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery.
  Ulm; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Berlin; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Berlin; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Berlin; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Dresden; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Kassel; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Leipzig; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Marburg; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Munchen; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Naumburg; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Oranienburg; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Ulm; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Wolfach; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Achim; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Annaberg-Buchholz; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Augsburg; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Böblingen; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Bad Neustadt; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Bamberg; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Berg; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Berlin; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Bielefeld; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Blankenberg (Harz); UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Bochum; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Bonn; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Butzbach; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Düsseldorf; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Dresden; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Emmendingen; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Erbach; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Flensburg; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Frankfurt am Main; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Friedberg (Hessen); UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Grevenbroich; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Halle (Saale); UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Hamburg; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Hemmoor; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Herborn; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Hildesheim; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Jülich; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Köln; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Karlstadt; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Leutkirch im Allgau; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Lutherstadt Eisleben; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  München; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Naumburg (Saale); UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Neuberg; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Oberhausen; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Oberursel (Taunus); UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Oldenburg; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Oranienburg; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Osnabrück; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Ostfildern; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Rheda-Wiedenbrück; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Rottenburg am Neckar; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Rottweil; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Schriesheim; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Schwerin; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Singen (Hohentwiel); UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Starnberg; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Stuttgart; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Ulm; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Unterhaching; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Wolfach; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Zwickau; UCB Clinical Trial Call Center
  
  

Guatemala

• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Zona 14; Unidad de Diagnostico Cardiologico
  
  
• Parkinson's Disease: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Zona 14; Unidad de Diagnostico Cardiologico
  
  

Hong Kong

• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Shatin, New Territories; U. of Hong Kong, Shatin- Prince of Wales Hospital
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Hong Kong; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Shatin, New Territories; U. of Hong Kong, Shatin- Prince of Wales Hospital
  
  

Hungary

• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Budapest; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Debrecen; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Pecs; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Szeged; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Zalaegerszeg; UCB Clinical Trial Call Center
  
  
• Multiple Sclerosis: Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323
  Budapest; UCB Clinical Trial Call Center
  
  
• Multiple Sclerosis: Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323
  Budapest; UCB Clinical Trial Call Center
  
  
• Multiple Sclerosis: Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323
  Gyor; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Budapest; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Debrecen; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Debrecen; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Nyiregyhaza; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Pécs; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Zalaegerszeg; UCB Clinical Trial Call Center
  
  

India

• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Bangalore; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Hyderabad; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Hyderabad; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Mumbai; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Mumbai; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  New Delhi; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Pune Maharashtra; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Tirupati; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Bangalore; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Hyderabad; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Jaipur; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Kolkata; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Lucknow; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Mumbai; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Pune; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Thiruvananthapuram; UCB Clinical Trial Call Center
  
  

Ireland

• Narcolepsy: Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
  Dublin 7; UCB Clinical Trial Call Center
  
  

Israel

• Alzheimer Disease: A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.
  Ramat Gan; Research Site:
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Tel Aviv; UCB Clinical Trial Call Center
  
  

Italy

• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Chieti Scalo; Centro Studi L’invecchiamento Oncology and Neuroscience
  
  
• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Milano; Istituti Clinici di Perfezionamento
  
  
• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Pavia; IRCCS Istituto Neurologico “C Mondino
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Bari; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Milano; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Milano; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Pavia; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Roma; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Siena; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Bologna; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Bologna; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Milano; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Napoli; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Chieti Scalo; Centro Studi L’invecchiamento Oncology and Neuroscience
  
  
• Parkinson's Disease: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Milano; Istituti Clinici di Perfezionamento
  
  
• Parkinson's Disease: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Pavia; IRCCS Istituto Neurologico “C Mondino
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Chieti; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Milano; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Pavia; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Torino; UCB Clinical Trial Call Center
  
  

Korea

• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Gwangju; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Seoul; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Seoul; UCB Clinical Trial Call Center
  
  

Mexico

• Epilepsy: The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
  San Juan, PR; Research Site
  
  
• Seizure Disorders: Conversion to Monotherapy Study With Keppra XR for Partial Seizures
  Aguascalientes; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Conversion to Monotherapy Study With Keppra XR for Partial Seizures
  Distrio federal; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Conversion to Monotherapy Study With Keppra XR for Partial Seizures
  Guadalajara; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Conversion to Monotherapy Study With Keppra XR for Partial Seizures
  Guadalajara Jalisco; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Aguascalientes; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Chihuahua; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Mexico City; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Mexico DF; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Monterrey; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Monterrey, NL; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Nuevo León; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  San Luis Potosi; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Zapopan, Jalisco; UCB Clinical Trial Call Center
  
  

Netherlands

• Alzheimer Disease: A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.
  Amsterdam; Research Site:
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Breda; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Den Haag; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Maastricht; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Zwolle; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Heemstede; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Heeze; UCB Clinical Trial Call Center
  
  
• Multiple Sclerosis: Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323
  Nieuwegein; UCB Clinical Trial Call Center
  
  
• Multiple Sclerosis: Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323
  Nijmegen; UCB Clinical Trial Call Center
  
  

New Zealand

• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Christ Church; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Wellington; UCB Clinical Trial Call Center
  
  

Norway

• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Bergen; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Fredrikstad; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Oslo; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Sandvika; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Trondheim; UCB Clinical Trial Call Center
  
  

Peru

• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  La Victoria, Lima; Hospital Nacional Guiillermo Almenarea Irigoyen
  
  
• Parkinson's Disease: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  La Victoria, Lima; Hospital Nacional Guiillermo Almenarea Irigoyen
  
  

Poland

• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Bialystok; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Gdansk; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Katowice; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Kielce; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Lodz; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Lublin; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Szczecin; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Warsaw; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Warszawa; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Warszawa; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Gdansk; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Katowice; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Lodz; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Lodz; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Lublin; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Szczecin; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Warszawa; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Warszawa; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Gdansk; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Krakow; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Lublin; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Olsztyn; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Warszawa; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Warszawa; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Conversion to Monotherapy Study With Keppra XR for Partial Seizures
  Bialystok; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Conversion to Monotherapy Study With Keppra XR for Partial Seizures
  Gdansk; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Conversion to Monotherapy Study With Keppra XR for Partial Seizures
  Katowice; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Conversion to Monotherapy Study With Keppra XR for Partial Seizures
  Krakow; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Conversion to Monotherapy Study With Keppra XR for Partial Seizures
  Lodz; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Conversion to Monotherapy Study With Keppra XR for Partial Seizures
  Lublin; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Conversion to Monotherapy Study With Keppra XR for Partial Seizures
  Poznan; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Conversion to Monotherapy Study With Keppra XR for Partial Seizures
  Poznan; UCB Clinical Trial Call Center
  
  
• Seizure Disorders: Conversion to Monotherapy Study With Keppra XR for Partial Seizures
  Warszawa; UCB Clinical Trial Call Center
  
  

Portugal

• Sleep Apnea Sydromes: A Study of the Effect of CPAP in Patients With Diastolic Heart Failure and Sleep-Related Breathing Disorder.
  Coimbra; Research Site:
  
  
• Sleep Apnea Sydromes: A Study of the Effect of CPAP in Patients With Diastolic Heart Failure and Sleep-Related Breathing Disorder.
  Porto; Research Site:
  
  

Puerto Rico

• Epilepsy: The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
  San Juan; Research Site
  
  

Republic of Korea

• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Seoul; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Seoul; UCB Clinical Trial Call Center
  
  

Russian Federation

• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Kazan; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Moscow; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Moscow; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Moscow; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Moscow; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Moscow; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Moscow; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Samara; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  St. Petersburg; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Yaroslavi; UCB Clinical Trial Call Center
  
  

Serbia and Montenegro

• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Belgrade; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Belgrade; UCB Clinical Trial Call Center
  
  

Singapore

• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Singapore; National Neuroscience Institute: Dept. of Neurology
  
  
• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Singapore; Singapore General Hospital, Department of Neurology
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Singapore; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Singapore; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Singapore; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Singapore; National Neuroscience Institute: Dept. of Neurology
  
  
• Parkinson's Disease: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Singapore; Singapore General Hospital, Department of Neurology
  
  

South Africa

• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Pretoria, Gauteng; willows MR Medical Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  George; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Johannesburg; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Tygeberg; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Pretoria, Gauteng; willows MR Medical Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Cape Town; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Capetown; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Johannesburg; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Pretoria/Gauteng; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Tygerberg; UCB Clinical Trial Call Center
  
  

Spain

• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Barcelona; Hospital de la Santa Creu i de Sant Pau
  
  
• Dyskinesias: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Madrid; Hospital Gregorio Maranon
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Alcorcon; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Barcelona; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Madrid; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  San Sebastian; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Vigo; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Madrid; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Madrid; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Madrid; UCB Clinical Trial Call Center
  
  
• Narcolepsy: Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
  Barcelona; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Barcelona; Hospital de la Santa Creu i de Sant Pau
  
  
• Parkinson's Disease: A clinical study designed to help reduce uncontrolled movements and rigidity caused by levodopa in people with Parkinson’s disease.
  Madrid; Hospital Gregorio Maranon
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Alzira; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Barakaldo; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Barcelona; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Madrid; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Madrid; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Madrid; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Alicante; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Barcelona; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Burgos; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Córdoba; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Ciudad Real; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Girona; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  La Linea de la Concepcion; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Las Palmas de Gran Canaria; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Madrid; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Oviedo; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Palma de Mallorca; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Sant Cugat del Vallés; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Sevilla; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Transdermal Rotigotine User Surveillance Study
  Valencia; UCB Clinical Trial Call Center
  
  
• Sleep Apnea Sydromes: A Study of the Effect of CPAP in Patients With Diastolic Heart Failure and Sleep-Related Breathing Disorder.
  Madrid; Research Site:
  
  
• Sleep Apnea Sydromes: A Study of the Effect of CPAP in Patients With Diastolic Heart Failure and Sleep-Related Breathing Disorder.
  Santander; Research Site:
  
  
• Sleep Apnea Sydromes: A Study of the Effect of CPAP in Patients With Diastolic Heart Failure and Sleep-Related Breathing Disorder.
  Santiago; Research Site:
  
  
• Sleep Apnea Sydromes: A Study of the Effect of CPAP in Patients With Diastolic Heart Failure and Sleep-Related Breathing Disorder.
  Valladolid; Research Site:
  
  
• Sleep Apnea Sydromes: A Study of the Effect of CPAP in Patients With Diastolic Heart Failure and Sleep-Related Breathing Disorder.
  Vitoria; Research Site:
  
  

Sweden

• Alzheimer Disease: A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.
  Malmoe; Research Site:
  
  
• Alzheimer Disease: A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.
  Stockholm; Research Site:
  
  
• Alzheimer Disease: A Single Dose Study of R1450 in Patients With Alzheimer Disease.
  Huddinge; Research Site:
  
  
• Alzheimer Disease: A Single Dose Study of R1450 in Patients With Alzheimer Disease.
  Malmoe; Research Site:
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Göteborg; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Stockholm; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Stockholm; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Umea; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Goteborg; UCB Clinical Trial Call Center
  
  

Sweeden

• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Stockholm; UCB Clinical Trial Call Center
  
  

Switzerland

• Chest Pain: A Study to Evaluate the Benefit of Cardiovascular Risk Stratification in Patients With Chest Pain.
  Zurich; Research Site:
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Biel; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Geneve; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  St Gallen; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Tschugg; UCB Clinical Trial Call Center
  
  
• Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  Zürich; UCB Clinical Trial Call Center
  
  
• Migraine and Cluster Headaches: Percitaneous Closure of Patent Foramen Ovale in Migraine with Aura - A Randomized Prospective Study: PRIMA Migraine Clinical Trial
  Various Cities; Research Center
  
  
• Migraine and Cluster Headaches: Whether subjects with percutaneous PFO closure experience a reduction in migraine attacks.
  Various Cities; Research Site
  
  
• Neurologic Disorders: Whether subjects with percutaneous PFO closure experience a reduction in migraine attacks.
  Various Cities; Research Site
  
  

Tunisia

• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  La Manouba; UCB Clinical Trial Call Center
  
  
• Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
  Tunis; UCB Clinical Trial Call Center
  
  

Ukraine

• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Donetsk; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Kharkov; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Kyiv; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Kyiv; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Lviv; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Odessa; UCB Clinical Trial Call Center
  
  
• Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  Uzhgorod; UCB Clinical Trial Call Center
  
  

United Kingdom

• Alzheimer Disease: A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.
  Blackpool; Research Site:
  
  
• Alzheimer Disease: A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.
  Glasgow; Research Site:
  
  
• Alzheimer Disease: A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.
  Penarth; Research Site:
  
  
• Alzheimer Disease: A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.
  Southampton; Research Site:
  
  
• Alzheimer Disease: A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.
  Swindon; Research Site:
  
  
• Alzheimer Disease: A Single Dose Study of R1450 in Patients With Alzheimer Disease.
  Bradford; Research Center
  
  
• Migraine and Cluster Headaches: Percitaneous Closure of Patent Foramen Ovale in Migraine with Aura - A Randomized Prospective Study: PRIMA Migraine Clinical Trial
  Brighton; Brighton and Sussex University Hospital
  
  
• Migraine and Cluster Headaches: Percitaneous Closure of Patent Foramen Ovale in Migraine with Aura - A Randomized Prospective Study: PRIMA Migraine Clinical Trial
  London; St. Mary's Hospital
  
  
• Migraine and Cluster Headaches: Whether subjects with percutaneous PFO closure experience a reduction in migraine attacks.
  Various Cities; Research Site
  
  
• Multiple Sclerosis: Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323
  Newcastle; UCB Clinical Trial Call Center
  
  
• Multiple Sclerosis: Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323
  Sheffield; UCB Clinical Trial Call Center
  
  
• Narcolepsy: Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
  Cambridge; UCB Clinical Trial Call Center
  
  
• Neurologic Disorders: Whether subjects with percutaneous PFO closure experience a reduction in migraine attacks.
  Various Cities; Research Site
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Bristol; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Lancashire; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  Liverpool; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  London; UCB Clinical Trial Call Center
  
  
• Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
  North Shields; UCB Clinical Trial Call Center